Cell-cycle and proliferation-related genes, such as for example Ki67, have been used for many decades to describe breast tumors: High levels of Ki67 have been correlated with worse prognosis and are also known to be associated with high tumor grade and negativity of estrogen receptor status [44,45]. Here, MKI67 is linked to neoplasm.